Predicting Glycogen Storage Diseases (Pompe Disease) And Decision Support
AssigneeCerner Innovation, Inc.
InventorDouglas S. McNair
Life of this patent
Estimating the term…
Loading patent…
AssigneeCerner Innovation, Inc.
InventorDouglas S. McNair
Estimating the term…
A diagnostic and decision support technology is provided for determining the presence, identity, and/or severity of an inherited lysosomal storage disorder. In particular, a mechanism is provided to detect and classify a lysosomal storage disorder in a human patient, which utilizes a logistic regression classifier determined based on a multi-variable-composite-biomarker comprising a specific set of physiological variables of the patient. This multi-variable statistical predictive biomarker approach may be employed for identifying persons whose attributes are consistent with features or glycogen storage diseases, such as late-onset Pompe disease.
A computerized method of initiating an electronic health record (EHR) intervention action for glycogen storage disease, the method comprising:
Dependencies are inferred from the claim text.